Suppr超能文献

生长因子和细胞因子在伤口愈合中的临床应用

Clinical application of growth factors and cytokines in wound healing.

作者信息

Barrientos Stephan, Brem Harold, Stojadinovic Olivera, Tomic-Canic Marjana

机构信息

Division of Wound Healing and Regenerative Medicine, Department of Surgery, Winthrop University Hospital/Stony Brook University School of Medicine, Mineola, New York.

出版信息

Wound Repair Regen. 2014 Sep-Oct;22(5):569-78. doi: 10.1111/wrr.12205.

Abstract

Wound healing is a complex and dynamic biological process that involves the coordinated efforts of multiple cell types and is executed and regulated by numerous growth factors and cytokines. There has been a drive in the past two decades to study the therapeutic effects of various growth factors in the clinical management of nonhealing wounds (e.g., pressure ulcers, chronic venous ulcers, diabetic foot ulcers). For this review, we conducted an online search of Medline/PubMed and critically analyzed the literature regarding the role of growth factors and cytokines in the management of these wounds. We focused on currently approved therapies, emerging therapies, and future research possibilities. In this review, we discuss four growth factors and cytokines currently being used on and off label for the healing of wounds. These include granulocyte-macrophage colony-stimulating factor, platelet-derived growth factor, vascular endothelial growth factor, and basic fibroblast growth factor. While the clinical results of using growth factors and cytokines are encouraging, many studies involved a small sample size and are disparate in measured endpoints. Therefore, further research is required to provide definitive evidence of efficacy.

摘要

伤口愈合是一个复杂且动态的生物学过程,涉及多种细胞类型的协同作用,并由众多生长因子和细胞因子执行和调节。在过去二十年中,人们一直致力于研究各种生长因子在难愈合伤口(如压疮、慢性静脉溃疡、糖尿病足溃疡)临床管理中的治疗效果。在本次综述中,我们对Medline/PubMed进行了在线搜索,并批判性地分析了有关生长因子和细胞因子在这些伤口管理中作用的文献。我们重点关注目前已获批的疗法、新兴疗法以及未来的研究可能性。在本综述中,我们讨论了目前正在用于伤口愈合且有适应证外使用情况的四种生长因子和细胞因子。这些包括粒细胞-巨噬细胞集落刺激因子、血小板衍生生长因子、血管内皮生长因子和碱性成纤维细胞生长因子。虽然使用生长因子和细胞因子的临床结果令人鼓舞,但许多研究样本量较小,且测量终点存在差异。因此,需要进一步研究以提供疗效的确切证据。

相似文献

1
Clinical application of growth factors and cytokines in wound healing.
Wound Repair Regen. 2014 Sep-Oct;22(5):569-78. doi: 10.1111/wrr.12205.
2
Emerging new drugs for wound repair.
Expert Opin Emerg Drugs. 2006 Mar;11(1):23-37. doi: 10.1517/14728214.11.1.23.
3
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.
Ann Surg. 2000 Apr;231(4):600-11. doi: 10.1097/00000658-200004000-00020.
4
Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.
Rev Endocr Metab Disord. 2019 Jun;20(2):207-217. doi: 10.1007/s11154-019-09492-1.
7
Long-term outcome study of growth factor-treated pressure ulcers.
Am J Surg. 2001 Jan;181(1):81-6. doi: 10.1016/s0002-9610(00)00536-5.
8
Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation.
Int J Low Extrem Wounds. 2013 Dec;12(4):256-64. doi: 10.1177/1534734613513401. Epub 2013 Nov 25.
10
Growth factors for treating diabetic foot ulcers.
Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD008548. doi: 10.1002/14651858.CD008548.pub2.

引用本文的文献

2
L. extract Attenuates Angiogenesis Through HIF-1α and WNT Mediated Blockage of VEGF/Angiopoietin Axis.
Dose Response. 2025 Aug 19;23(3):15593258251367613. doi: 10.1177/15593258251367613. eCollection 2025 Jul-Sep.
3
Exploring the influence of growth factors in diabetic foot: A comprehensive bibliometric analysis.
Medicine (Baltimore). 2025 Aug 1;104(31):e42716. doi: 10.1097/MD.0000000000042716.
5
A dual-component particulate dressing for simultaneous microenvironment modulation and tissue regeneration in infected diabetic wounds.
Mater Today Bio. 2025 Jun 18;33:102005. doi: 10.1016/j.mtbio.2025.102005. eCollection 2025 Aug.
7
: Characterizing dynamics of cells using single-cell RNA-sequencing.
bioRxiv. 2025 May 22:2025.05.16.654572. doi: 10.1101/2025.05.16.654572.
10
Topical metformin in wound healing: a comprehensive systematic review of therapeutic outcomes.
Arch Dermatol Res. 2025 May 16;317(1):760. doi: 10.1007/s00403-025-04277-w.

本文引用的文献

1
Acute lung injury following the use of granulocyte-macrophage colony-stimulating factor.
Int J Crit Illn Inj Sci. 2013 Oct;3(4):279-81. doi: 10.4103/2229-5151.124168.
2
3
High cost of stage IV pressure ulcers.
Am J Surg. 2010 Oct;200(4):473-7. doi: 10.1016/j.amjsurg.2009.12.021.
5
Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers.
Mol Med. 2010 Mar;16(3-4):92-101. doi: 10.2119/molmed.2009.00149. Epub 2010 Jan 6.
6
Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines.
Br J Dermatol. 2010 Mar;162(3):478-86. doi: 10.1111/j.1365-2133.2009.09528.x. Epub 2009 Oct 3.
7
A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns.
Wound Repair Regen. 2009 Sep-Oct;17(5):685-9. doi: 10.1111/j.1524-475X.2009.00526.x.
8
Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease.
Mol Ther. 2009 Oct;17(10):1822-9. doi: 10.1038/mt.2009.169. Epub 2009 Jul 28.
9
Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer.
Eur J Dermatol. 2009 Sep-Oct;19(5):461-8. doi: 10.1684/ejd.2009.0750. Epub 2009 Jul 29.
10
Operative debridement of pressure ulcers.
World J Surg. 2009 Jul;33(7):1396-402. doi: 10.1007/s00268-009-0024-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验